REGGIE PET LIMITED – Trademark Portfolio

Entity Type: 24

REGGIE PET LIMITED holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 1 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include REGGIE. The owner is based in ST ALBANS.

18A ONSLOW STREET

ST ALBANS 8014 , NZ

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

REGGIE
REGGIE
Registered 2021
REGGIE
REGGIE
Registered 2020

Trademark Classifications

REGGIE PET LIMITED's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does REGGIE PET LIMITED have?

REGGIE PET LIMITED has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does REGGIE PET LIMITED file in?

REGGIE PET LIMITED files trademarks across 2 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 5 (Pharmaceuticals). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.

What are REGGIE PET LIMITED's most well-known trademarks?

REGGIE PET LIMITED's registered trademark portfolio includes well-known marks such as REGGIE. These are among 2 currently registered trademarks in the portfolio.

What is REGGIE PET LIMITED's trademark registration success rate?

REGGIE PET LIMITED has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.